milrinone has been researched along with morphine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, S; Itzhak, Y; Kalir, A; Weissman, BA | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Forde, MD; Wilson, TD | 1 |
| Donlan, SM; Gheorghiade, M; Pang, PS; Quattromani, E | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Bai, YL; Chen, YY; Chu, QJ; Li, J; Li, WJ; Zhang, Q | 1 |
3 review(s) available for milrinone and morphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Therapy for acute heart failure syndromes.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Milrinone; Mineralocorticoid Receptor Antagonists; Morphine; Nitroprusside; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Syndrome; Treatment Outcome | 2009 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
7 other study(ies) available for milrinone and morphine
| Article | Year |
|---|---|
New analgesic drugs derived from phencyclidine.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Lethal Dose 50; Male; Mice; Motor Activity; Phencyclidine; Reaction Time | 1981 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Stability of milrinone and epinephrine, atropine sulfate, lidocaine hydrochloride, or morphine sulfate injection.
Topics: Atropine; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Epinephrine; Indicators and Reagents; Lidocaine; Milrinone; Morphine; Pyridones | 1990 |
A comparison of the effects of digoxin, ouabain and milrinone on naloxone-precipitated withdrawal syndrome in mice.
Topics: Animals; Cardiotonic Agents; Digoxin; Female; Male; Mice; Milrinone; Morphine; Motor Activity; Naloxone; Ouabain; Sodium-Potassium-Exchanging ATPase; Substance Withdrawal Syndrome; Weight Loss | 2012 |